NCT00572338

Therapeutic Research in Multiple Myeloma

UARK 91-004 Therapeutic Research in Multiple Myeloma

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 6,388 (actual)
• Sponsor: University of Arkansas · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.

Detailed description

Participating in this study will require that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of your multiple myeloma. Bone marrow/peripheral blood/tissue samples will be collected for research purposes, as well as testing for genetic traits of Castleman's disease if you consent to this study. In addition, data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results, treatment protocols, dates of relapses, subsequent treatment protocols, and current treatments and medications.

Conditions

• Multiple Myeloma

Interventions

Type	Name	Description
OTHER	No drugs are involved	No treatment or drugs are involved in this research. Participating in this study requires that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of participant's multiple myeloma. Bone marrow/peripheral blood samples will be collected at the same time for research purposes. Data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results, treatment protocols, dates of relapses, subsequent treatment protocols, and current treatments and medications.

Timeline

• Start date: 2003-08-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2007-12-13
• Last updated: 2015-08-13

Locations

1 site across 1 country: United States